READ THIS – If You Missed Out On The AI Boom

Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”

Click on Adam's shiny forehead for more details.

RPRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 18.72%

Insider Buying (Last 12 Months): $15,543,025.16

Insider Selling (Last 12 Months): $72,415,950.97

Royalty Pharma Insider Trading History Chart

Royalty Pharma Share Price & Price History

^$28.12

▲ +0.12 (0.43%)

As of 04/29/2024 01:00 AM ET

Days: 30 | 90 | 365

READ THIS – If You Missed Out On The AI Boom

From Banyan Hill Publishing | Ad

Click on Adam's shiny forehead for more details.

Royalty Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/4/2024	Rory B. Riggs	Director	Sell	35,702	$27.55	$983,590.10	20,099
1/2/2024	Rory B. Riggs	Director	Sell	235,200	$28.52	$6,707,904.00	254,899
12/27/2023	Avara Management Ltd	Major Shareholder	Sell	41,729	$28.01	$1,168,829.29	2,753,186
8/9/2023	Terrance P Coyne	CFO	Sell	37,500	$30.72	$1,152,000.00	827,500
7/12/2023	Terrance P Coyne	CFO	Sell	37,500	$31.07	$1,165,125.00	902,500
6/28/2023	Pablo G Legorreta	CEO	Buy	130,000	$29.51	$3,836,300.00	600,000
6/12/2023	Pablo G Legorreta	CEO	Buy	45,000	$33.00	$1,485,000.00	425,000
6/5/2023	George W. Lloyd	EVP	Sell	19,215	$33.54	$644,471.10	109,099
6/2/2023	George W. Lloyd	EVP	Sell	93,907	$33.64	$3,159,031.48	120,000
5/24/2023	Pablo G Legorreta	CEO	Buy	150,000	$32.25	$4,837,500.00	380,000
5/22/2023	Rory B. Riggs	Director	Sell	1,750,000	$32.82	$57,435,000.00	6,762
5/16/2023	Pablo G Legorreta	CEO	Buy	160,388	$33.57	$5,384,225.16	160,388
3/29/2023	Rory B. Riggs	Director	Sell	9,926	$36.95	$366,765.70	1,586,786
3/28/2023	George W. Lloyd	EVP	Sell	100,000	$37.06	$3,706,000.00	225,000
2/22/2023	Marshall Urist	EVP	Sell	23,333	$37.30	$870,320.90	46,667
12/12/2022	Rory B. Riggs	Director	Sell	40,010	$41.98	$1,679,619.80	96,712
12/9/2022	Rory B. Riggs	Director	Sell	19,990	$42.07	$840,979.30	136,722
12/5/2022	Mario Germano Giuliani	Director	Sell	84,302	$43.15	$3,637,631.30	7,795,072
12/1/2022	Mario Germano Giuliani	Director	Sell	165,000	$44.10	$7,276,500.00	22,225,000
11/21/2022	George W. Lloyd	EVP	Sell	23,631	$43.11	$1,018,732.41	144,469
11/17/2022	Rory B. Riggs	Director	Sell	120,000	$42.33	$5,079,600.00	156,712
11/10/2022	George W. Lloyd	EVP	Sell	50,000	$43.85	$2,192,500.00	165,000
11/8/2022	Terrance P Coyne	CFO	Sell	24,500	$43.47	$1,065,015.00	940,000
11/2/2022	Terrance P Coyne	CFO	Sell	5,500	$43.06	$236,830.00	964,500
9/28/2022	James F. Reddoch	EVP	Sell	100,000	$41.23	$4,123,000.00	820,800
9/28/2022	Mario Germano Giuliani	Director	Sell	32,593	$41.05	$1,337,942.65	8,077,140
9/21/2022	Mario Germano Giuliani	Director	Sell	125,697	$41.25	$5,185,001.25	8,321,113
9/20/2022	1978 Sicaf Sif S.A. - Gg St Gg	Major Shareholder	Sell	267,815	$41.02	$10,985,771.30	21,426,170
9/19/2022	Mario Germano Giuliani	Director	Sell	232,185	$41.50	$9,635,677.50	22,657,815
9/16/2022	Mario Germano Giuliani	Director	Sell	154,986	$41.72	$6,466,015.92	22,890,000
9/14/2022	1978 Sicaf Sif S.A. Gg	Major Shareholder	Sell	190,860	$42.48	$8,107,732.80	22,235,310
9/14/2022	Rory B. Riggs	Director	Sell	47,975	$42.41	$2,034,619.75	328,737
9/7/2022	1978 Sicaf Sif S.A. - Gg St Gg	Major Shareholder	Sell	250,000	$42.53	$10,632,500.00	22,674,176
9/7/2022	Mario Germano Giuliani	Director	Sell	261,881	$42.66	$11,171,843.46	8,814,759
8/25/2022	1978 Sicaf Sif S.A. - Gg St Gg	Major Shareholder	Sell	1,994	$44.00	$87,736.00	22,924,176
8/25/2022	Mario Germano Giuliani	Director	Sell	500	$44.00	$22,000.00	9,076,640
8/9/2022	George W. Lloyd	EVP	Sell	11,859	$43.92	$520,847.28	210,109
8/9/2022	Rory B. Riggs	Director	Sell	45,000	$43.73	$1,967,850.00	376,712
8/1/2022	Terrance P Coyne	CFO	Sell	30,000	$43.19	$1,295,700.00	970,000
7/27/2022	George W. Lloyd	EVP	Sell	25,100	$43.76	$1,098,376.00	226,014
7/25/2022	George W. Lloyd	EVP	Sell	30,671	$42.93	$1,316,706.03	228,886
6/29/2022	Rory B. Riggs	Director	Sell	30,000	$42.17	$1,265,100.00	421,712
6/24/2022	Marshall Urist	EVP	Sell	23,333	$43.19	$1,007,752.27	23,334
6/8/2022	James F. Reddoch	EVP	Sell	100,000	$41.56	$4,156,000.00	920,800
5/27/2022	James F. Reddoch	EVP	Sell	75,000	$41.08	$3,081,000.00	1,020,800
5/23/2022	George W. Lloyd	EVP	Sell	100,000	$40.27	$4,027,000.00	530,000
5/19/2022	James F. Reddoch	EVP	Sell	75,000	$40.44	$3,033,000.00	1,095,800
5/19/2022	Rory B. Riggs	Director	Sell	26,304	$40.09	$1,054,527.36	575,408
5/16/2022	Marshall Urist	EVP	Sell	23,333	$39.85	$929,820.05	46,667
3/29/2022	Rory B. Riggs	Director	Sell	60,000	$38.59	$2,315,400.00
3/21/2022	Rory B. Riggs	Director	Sell	39,867	$39.05	$1,556,806.35
3/18/2022	Rory B. Riggs	Director	Sell	129,222	$39.55	$5,110,730.10
2/24/2022	Henry A. Fernandez	Director	Buy	32,500	$37.49	$1,218,425.00
12/28/2021	Rory B. Riggs	Director	Sell	109,448	$40.21	$4,400,904.08
11/16/2021	George W. Lloyd	EVP	Sell	165,852	$42.39	$7,030,466.28
11/16/2021	Rory B. Riggs	Director	Sell	12,565	$42.01	$527,855.65
9/28/2021	Rory B. Riggs	Director	Sell	40,000	$36.75	$1,470,000.00
7/26/2021	George W. Lloyd	EVP	Sell	13,362	$39.78	$531,540.36
7/14/2021	James F. Reddoch	EVP	Sell	2	$42.00	$84.00
7/12/2021	George W. Lloyd	EVP	Sell	100	$42.04	$4,204.00	3,000
7/8/2021	James F. Reddoch	EVP	Sell	40,655	$42.05	$1,709,542.75	3,000
7/6/2021	James F. Reddoch	EVP	Sell	30,270	$42.40	$1,283,448.00	3,000
6/28/2021	Rory B. Riggs	Director	Sell	167,448	$42.11	$7,051,235.28	679,760
6/25/2021	Rory B. Riggs	Director	Sell	666,464	$42.72	$28,471,342.08	679,760
6/10/2021	George W. Lloyd	EVP	Sell	70,000	$46.49	$3,254,300.00	3,000
6/7/2021	Marshall Urist	EVP	Sell	16,568	$47.02	$779,027.36	16,568
6/4/2021	Marshall Urist	EVP	Sell	16,566	$45.13	$747,623.58	16,568
6/2/2021	Marshall Urist	EVP	Sell	14,566	$41.52	$604,780.32

READ THIS – If You Missed Out On The AI Boom

From Banyan Hill Publishing | Ad

Click on Adam's shiny forehead for more details.

SEC Filings (Institutional Ownership Changes) for Royalty Pharma (NASDAQ:RPRX)

54.35% of Royalty Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Royalty Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/29/2024	Phillips Wealth Planners LLC	7,947	$0.24M	0.3%	N/A	0.001%
4/29/2024	China Universal Asset Management Co. Ltd.	85,879	$2.61M	0.3%	+66.2%	0.014%
4/26/2024	SYSTM Wealth Solutions LLC	32,836	$1M	0.1%	+247.0%	0.005%
4/25/2024	Zurcher Kantonalbank Zurich Cantonalbank	171,661	$5.23M	0.0%	+22.3%	0.029%
4/25/2024	Aubrey Capital Management Ltd	30,619	$0.93M	0.3%	-7.5%	0.005%
4/25/2024	Fjarde AP Fonden Fourth Swedish National Pension Fund	94,550	$2.87M	0.0%	-17.0%	0.016%
4/22/2024	Compound Global Advisors LLC	396,342	$12.04M	1.8%	-17.3%	0.066%
4/22/2024	Raymond James & Associates	784,549	$23.83M	0.0%	+250.8%	0.131%
4/19/2024	New Century Financial Group LLC	35,908	$1.09M	0.8%	N/A	0.006%
4/19/2024	Sumitomo Mitsui Trust Holdings Inc.	931,360	$28.29M	0.0%	-8.6%	0.156%
4/18/2024	Allspring Global Investments Holdings LLC	2,750	$84K	0.0%	+4,335.5%	0.000%
4/18/2024	Park Place Capital Corp	5,068	$0.15M	0.1%	-10.4%	0.001%
4/16/2024	Overbrook Management Corp	209,349	$6.36M	1.7%	-4.7%	0.035%
4/11/2024	Ballentine Partners LLC	12,541	$0.38M	0.0%	+3.3%	0.002%
4/11/2024	Financiere des Professionnels Fonds d investissement inc.	32,931	$1M	0.1%	N/A	0.006%
4/9/2024	Alaska Permanent Fund Corp	83,790	$2.55M	0.0%	-2.1%	0.014%
4/5/2024	First Hawaiian Bank	10,119	$0.31M	0.0%	N/A	0.002%
4/5/2024	GAMMA Investing LLC	1,638	$50K	0.0%	+172.5%	0.000%
4/5/2024	Los Angeles Capital Management LLC	703,919	$21.38M	0.1%	+73.4%	0.118%
3/22/2024	PNC Financial Services Group Inc.	10,947	$0.31M	0.0%	+98.7%	0.002%
3/11/2024	Vanguard Group Inc.	37,997,522	$1.07B	0.0%	-3.7%	6.360%
3/1/2024	Goldman Sachs Group Inc.	2,869,546	$80.61M	0.0%	-31.8%	0.480%
2/27/2024	Geo Capital Gestora de Recursos Ltd	88,253	$2.48M	2.8%	-34.7%	0.015%
2/26/2024	Virtu Financial LLC	13,888	$0.39M	0.0%	+49.7%	0.002%
2/20/2024	Eventide Asset Management LLC	533,975	$15M	0.2%	-46.8%	0.089%
2/20/2024	Aurora Investment Counsel	40,558	$1.14M	0.7%	+7.0%	0.007%
2/15/2024	Patient Capital Management LLC	1,254,780	$35.25M	1.9%	N/A	0.210%
2/14/2024	ADAR1 Capital Management LLC	1,321,834	$37.13M	13.3%	N/A	0.221%
2/14/2024	Advanced Portfolio Management LLC	135,000	$3.79M	4.0%	-41.3%	0.023%
2/14/2024	Sectoral Asset Management Inc.	20,570	$0.58M	0.2%	+14.6%	0.003%
2/14/2024	Prudential PLC	14,002	$0.39M	0.0%	-78.4%	0.002%
2/14/2024	AdvisorShares Investments LLC	15,717	$0.44M	0.1%	N/A	0.003%
2/13/2024	Asahi Life Asset Management CO. LTD.	11,650	$0.33M	0.2%	N/A	0.002%
2/13/2024	Homestead Advisers Corp	1,345,540	$37.80M	1.0%	+0.2%	0.225%
2/13/2024	Public Employees Retirement Association of Colorado	44,450	$1.25M	0.0%	+257.3%	0.007%
2/13/2024	Lake Street Advisors Group LLC	7,191	$0.20M	0.0%	N/A	0.001%
2/13/2024	Rhenman & Partners Asset Management AB	429,697	$12.07M	1.2%	+186.5%	0.072%
2/13/2024	CIBC Asset Management Inc	11,859	$0.33M	0.0%	N/A	0.002%
2/13/2024	NEOS Investment Management LLC	8,589	$0.24M	0.0%	+5.0%	0.001%
2/13/2024	The Manufacturers Life Insurance Company	554,005	$15.56M	0.0%	+55.1%	0.093%
2/13/2024	KBC Group NV	30,026	$0.84M	0.0%	-66.4%	0.005%
2/13/2024	APG Asset Management US Inc.	74,757	$2.10M	0.0%	N/A	0.013%
2/13/2024	California State Teachers Retirement System	635,522	$17.85M	0.0%	+6.7%	0.106%
2/12/2024	Treasurer of the State of North Carolina	174,777	$4.91M	0.0%	+0.9%	0.029%
2/12/2024	Allianz Asset Management GmbH	65,082	$1.83M	0.0%	-45.3%	0.011%
2/12/2024	TD Asset Management Inc	220,183	$6.19M	0.0%	-24.2%	0.037%
2/12/2024	S&CO Inc.	332,110	$9.33M	0.7%	+31.0%	0.056%
2/12/2024	Eaton Financial Holdings Company LLC	50,592	$1.42M	0.3%	-5.2%	0.008%
2/12/2024	Parallel Advisors LLC	2,882	$81K	0.0%	+62.7%	0.000%
2/12/2024	Hsbc Holdings PLC	145,270	$4.06M	0.0%	+8.1%	0.024%
2/9/2024	Nomura Asset Management Co. Ltd.	121,899	$3.42M	0.0%	+30.9%	0.020%
2/9/2024	Oxford Asset Management LLP	10,835	$0.30M	0.5%	N/A	0.002%
2/9/2024	Commerce Bank	7,168	$0.20M	0.0%	N/A	0.001%
2/9/2024	EverSource Wealth Advisors LLC	1,807	$51K	0.0%	+79.8%	0.000%
2/9/2024	Aigen Investment Management LP	15,833	$0.45M	0.1%	-11.8%	0.003%
2/9/2024	Franklin Resources Inc.	96,361	$2.71M	0.0%	+36.4%	0.016%
2/9/2024	Trexquant Investment LP	432,589	$12.15M	0.3%	+37.5%	0.072%
2/9/2024	Corient Private Wealth LLC	21,346	$0.60M	0.0%	N/A	0.004%
2/9/2024	Hillsdale Investment Management Inc.	17,250	$0.49M	0.0%	+12.0%	0.003%
2/9/2024	UBS Group AG	866,995	$24.35M	0.0%	+16.5%	0.145%
2/9/2024	PNC Financial Services Group Inc.	10,947	$0.31M	0.0%	+98.7%	0.002%
2/9/2024	Dynamic Technology Lab Private Ltd	20,716	$0.58M	0.1%	N/A	0.003%
2/9/2024	Norges Bank	4,262,736	$119.74M	0.0%	N/A	0.714%
2/8/2024	ING Groep NV	46,200	$1.30M	0.0%	N/A	0.008%
2/8/2024	Robeco Institutional Asset Management B.V.	15,328	$0.43M	0.0%	+87.0%	0.003%
2/8/2024	Kingsview Wealth Management LLC	45,573	$1.28M	0.0%	N/A	0.008%
2/8/2024	Panagora Asset Management Inc.	281,015	$7.89M	0.0%	+326.6%	0.047%
2/8/2024	Quadrant Capital Group LLC	3,487	$98K	0.0%	+295.8%	0.001%
2/8/2024	Torray Investment Partners LLC	505,740	$14.21M	2.3%	+22.6%	0.085%
2/8/2024	Mitsubishi UFJ Asset Management Co. Ltd.	186,763	$5.18M	0.0%	+0.7%	0.031%
2/7/2024	Ieq Capital LLC	45,562	$1.28M	0.0%	-3.6%	0.008%
2/7/2024	Principal Financial Group Inc.	23,399	$0.66M	0.0%	-19.8%	0.004%
2/7/2024	Formidable Asset Management LLC	40,610	$1.14M	0.2%	-2.3%	0.007%
2/7/2024	Jump Financial LLC	11,300	$0.32M	0.0%	-94.4%	0.002%
2/7/2024	Teacher Retirement System of Texas	89,225	$2.51M	0.0%	-11.5%	0.015%
2/7/2024	Versor Investments LP	21,042	$0.59M	0.1%	N/A	0.004%
2/7/2024	Kovitz Investment Group Partners LLC	84,046	$2.36M	0.0%	-16.5%	0.014%
2/6/2024	Charles Schwab Investment Management Inc.	1,770,988	$49.75M	0.0%	+7.4%	0.296%
2/6/2024	Machina Capital S.A.S.	24,526	$0.69M	0.4%	N/A	0.004%
2/6/2024	Metis Global Partners LLC	13,367	$0.38M	0.0%	N/A	0.002%
2/6/2024	National Bank of Canada FI	34,872	$0.99M	0.0%	-69.5%	0.006%
2/6/2024	M&T Bank Corp	18,530	$0.52M	0.0%	+13.3%	0.003%
2/6/2024	Amalgamated Bank	32,077	$0.90M	0.0%	-10.3%	0.005%
2/6/2024	Summit Global Investments	8,915	$0.25M	0.0%	-20.3%	0.001%
2/6/2024	Los Angeles Capital Management LLC	405,971	$11.40M	0.0%	-5.9%	0.068%
2/6/2024	Swiss National Bank	1,193,200	$33.52M	0.0%	-2.6%	0.200%
2/6/2024	First Trust Direct Indexing L.P.	21,545	$0.61M	0.1%	+34.3%	0.004%
2/5/2024	Victory Capital Management Inc.	265,711	$7.46M	0.0%	-21.6%	0.044%
2/5/2024	Beck Bode LLC	73,042	$2.05M	0.5%	+0.6%	0.012%
2/5/2024	Van ECK Associates Corp	6,476	$0.18M	0.0%	+83.4%	0.001%
2/5/2024	PGGM Investments	89,470	$2.51M	0.0%	+2.3%	0.015%
2/5/2024	Russell Investments Group Ltd.	322,967	$9.06M	0.0%	+20.5%	0.054%
2/5/2024	Aubrey Capital Management Ltd	33,091	$0.93M	0.4%	N/A	0.006%
2/2/2024	Headlands Technologies LLC	23,085	$0.65M	0.2%	-2.1%	0.004%
2/2/2024	Truist Financial Corp	15,788	$0.44M	0.0%	N/A	0.003%
2/2/2024	Overbrook Management Corp	219,677	$6.17M	1.2%	-26.5%	0.037%
2/2/2024	Supplemental Annuity Collective Trust of NJ	17,000	$0.48M	0.2%	N/A	0.003%
2/2/2024	Stevens Capital Management LP	13,365	$0.38M	0.1%	N/A	0.002%
2/2/2024	NJ State Employees Deferred Compensation Plan	24,000	$0.67M	0.1%	N/A	0.004%
2/2/2024	Alaska Permanent Fund Corp	85,571	$2.40M	0.0%	-65.4%	0.014%

Data available starting January 2016

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Today's Range

Now: $28.12

$27.92

$28.25

50 Day Range

MA: $29.58

$27.46

$31.33

52 Week Range

Now: $28.12

$25.92

$35.76

Volume

3,605,078 shs

Average Volume

2,676,574 shs

Market Capitalization

$16.80 billion

P/E Ratio

14.88

Dividend Yield

2.99%

Beta

0.45

Who are the company insiders with the largest holdings of Royalty Pharma?: Royalty Pharma's top insider shareholders include:
1978 Sicaf Sif SA - Gg St Gg (Major Shareholder)
Mario Germano Giuliani (Director)
1978 Sicaf Sif SA Gg (Major Shareholder)
Avara Management Ltd (Major Shareholder)
Rory B Riggs (Director)
James F Reddoch (EVP)
Terrance P Coyne (CFO)
Pablo G Legorreta (CEO)
George W Lloyd (EVP)
Marshall Urist (EVP)
Learn More about top insider investors at Royalty Pharma.
Who are the major institutional investors of Royalty Pharma?: Royalty Pharma's top institutional investors include:
Sumitomo Mitsui Trust Holdings Inc. — 0.16%
Raymond James & Associates — 0.13%
Los Angeles Capital Management LLC — 0.12%
Compound Global Advisors LLC — 0.07%
Overbrook Management Corp — 0.04%
Zurcher Kantonalbank Zurich Cantonalbank — 0.03%
Learn More about top institutional investors of Royalty Pharma stock.
Which major investors are selling Royalty Pharma stock?: During the last quarter, RPRX stock was sold by these institutional investors:
Sumitomo Mitsui Trust Holdings Inc.
Compound Global Advisors LLC
Fjarde AP Fonden Fourth Swedish National Pension Fund
Overbrook Management Corp
Aubrey Capital Management Ltd
Alaska Permanent Fund Corp
Park Place Capital Corp
During the last year, company insiders that have sold Royalty Pharma company stock include:
1978 Sicaf Sif SA - Gg St Gg (Major Shareholder)
Mario Germano Giuliani (Director)
1978 Sicaf Sif SA Gg (Major Shareholder)
Avara Management Ltd (Major Shareholder)
Learn More investors selling Royalty Pharma stock.
Which major investors are buying Royalty Pharma stock?: Within the last quarter, RPRX stock was bought by institutional investors including:
Raymond James & Associates
Los Angeles Capital Management LLC
New Century Financial Group LLC
China Universal Asset Management Co. Ltd.
Financiere des Professionnels Fonds d investissement inc.
Zurcher Kantonalbank Zurich Cantonalbank
SYSTM Wealth Solutions LLC
First Hawaiian Bank

READ THIS – If You Missed Out On The AI Boom

From Banyan Hill Publishing | Ad

Click on Adam's shiny forehead for more details.

RPRX Insider Trading

Royalty Pharma Insider Trading History Chart

Royalty Pharma Share Price & Price History

Royalty Pharma Insider Trading History

SEC Filings (Institutional Ownership Changes) for Royalty Pharma (NASDAQ:RPRX)

Institutional Buying and Selling by Quarter

Royalty Pharma Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Royalty Pharma?

Who are the major institutional investors of Royalty Pharma?

Which major investors are selling Royalty Pharma stock?

Which major investors are buying Royalty Pharma stock?